Last week, the FDA approved XCOPRI (cenobamate tablets) to treat partial-onset seizures in adults. This approval will help offer additional aid for the many individuals throughout the world who live ...

POTIGA (ezogabine) 50mg, 200mg, 300mg, 400mg tablets by GlaxoSmithKline The FDA has approved Potiga (ezogabine tablets; Valeant and GlaxoSmithKline) as adjunct treatment for partial-onset seizures in ...

Since 1983, eight new AEDs have been introduced (see Table 2 below). Sadly, a recent VA study of more than 21,000 subjects aged 65 years and older revealed that 80% were being treated with ...

SK Life Science has announced the availability of Xcopri (cenobamate) tablets for the treatment of partial-onset seizures in adults.  SK Life Science has announced the availability of Xcopri ...

New findings from a phase 3 clinical trial suggest an additional therapeutic option may be coming down the pike. Researchers performed a randomized, double-blind, placebo-controlled study in the ...

Hope for Alzheimer's prevention emerges as scientists find existing seizure drug may stop disease progression if taken ...

VIENNA, Austria — Once-daily adjunctive therapy with eslicarbazepine significantly reduced the frequency of partial-onset seizures in adult patients compared with adding a placebo, and the effect was ...

The US Food and Drug Administration (FDA) has approved a supplemental new drug application for the antiepileptic drug lacosamide (Vimpat, UCB) as monotherapy in treating partial-onset seizures in ...

Moving forward The CDC reports that one in 100 U.S. adults has active epilepsy, and studies suggest that one third of these are not receiving adequate treatment or care. 30 Although this recent report ...